8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 DiabetesMatthias Eckhardt, Frank Himmelsbach, Leo Thomas et al.|Journal of Medicinal Chemistry|2007Cited by 285
8-(3-(<em>R</em>)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetesMatthias Eckhardt, Frank Himmelsbach, Elke Langkopf et al.|DORA PSI (Paul Scherrer Institute)|2007Cited by 0